To improve its products and services, a client needed the point-of-care HbA1c testing market mapped: test volumes and trends, purchase pricing, the organization types performing tests and how they're funded, prevalent brands and their shares, and the healthcare-policy outlook.
We conducted 50 in-depth discussions of 50 minutes each across EU5, China, Japan, Korea, and India — with HCPs, payers, and manufacturers in the same study. That's the network advantage: prescriber, funder, and supplier, one verified base.
Full engagement in eight weeks, including follow-up questions after the discussions.
When the decision chain spans three stakeholder types, the research should too. Talk to our team.